Literature DB >> 33472618

Gene expression pattern analysis using dual-color RT-MLPA and integrative genome-wide association studies of eQTL for tuberculosis suscepitibility.

Jing-Wen Ai1, Hanyue Zhang1, Zumo Zhou2, Shanshan Weng1, Heqing Huang2, Sen Wang1, Lingyun Shao1, Yan Gao1, Jing Wu1, Qiaoling Ruan1, Feifei Wang1, Ning Jiang3, Jiazhen Chen4, Wenhong Zhang5.   

Abstract

BACKGROUND: When infected with Mycobacterium tuberculosis, only a small proportion of the population will develop active TB, and the role of host genetic factors in different TB infection status was not fully understood.
METHODS: Forty-three patients with active tuberculosis and 49 with latent tuberculosis were enrolled in the prospective cohort. Expressing levels of 27 candidate mRNAs, which were previously demonstrated to differentially expressed in latent and active TB, were measured by dual color reverse transcription multiplex ligation dependent probe amplification assay (dcRT-MLPA). Using expression levels of these mRNAs as quantitative traits, associations between expression abundance and genome-wild single nucleotide polymorphisms (SNPs) were calculated. Finally, identified candidate SNPs were further assessed for their associations with TB infection status in a validation cohort with 313 Chinese Han cases.
RESULTS: We identified 9 differentially expressed mRNAs including il7r, il4, il8, tnfrsf1b, pgm5, ccl19, il2ra, marco and fpr1 in the prospective cohort. Through expression quantitative trait loci mapping, we screened out 8 SNPs associated with these mRNAs. Then, CG genotype of the SNP rs62292160 was finally verified to be significantly associated with higher transcription levels of IL4 in LTBI than in TB patients.
CONCLUSION: We reported that the SNP rs62292160 in Chinese Han population may link to higher expression of il4 in latent tuberculosis. Our findings provided a new genetic variation locus for further exploration of the mechanisms of TB and a possible target for TB genetic susceptibility studies, which might aid the clinical decision to precision treatment of TB.

Entities:  

Keywords:  Active tuberculosis infection; Expression quantitative trait loci; Genetic susceptibility; Latent tuberculosis; Single nucleotide polymorphisms

Mesh:

Substances:

Year:  2021        PMID: 33472618      PMCID: PMC7816316          DOI: 10.1186/s12931-020-01612-9

Source DB:  PubMed          Journal:  Respir Res        ISSN: 1465-9921


  39 in total

1.  Molecular evidence of endogenous reactivation of Mycobacterium tuberculosis after 33 years of latent infection.

Authors:  Troels Lillebaek; Asger Dirksen; Inga Baess; Benedicte Strunge; Vibeke Ø Thomsen; Ase B Andersen
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

2.  Bialellic Mutations in Tetratricopeptide Repeat Domain 7A (TTC7A) Cause Common Variable Immunodeficiency-Like Phenotype with Enteropathy.

Authors:  Dylan Lawless; Anoop Mistry; Philip M Wood; Jens Stahlschmidt; Gururaj Arumugakani; Mark Hull; David Parry; Rashida Anwar; Clive Carter; Sinisa Savic
Journal:  J Clin Immunol       Date:  2017-08-14       Impact factor: 8.317

3.  Deciphering the genetic architecture of variation in the immune response to Mycobacterium tuberculosis infection.

Authors:  Luis B Barreiro; Ludovic Tailleux; Athma A Pai; Brigitte Gicquel; John C Marioni; Yoav Gilad
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-10       Impact factor: 11.205

4.  Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca+2-dependent cell signaling.

Authors:  M Rojas; L F García; J Nigou; G Puzo; M Olivier
Journal:  J Infect Dis       Date:  2000-06-29       Impact factor: 5.226

5.  Interaction of the ubiquitin carboxyl terminal esterase L1 with alpha(2)-adrenergic receptors inhibits agonist-mediated p44/42 MAP kinase activation.

Authors:  Bernd Weber; Christian Schaper; Yi Wang; Jens Scholz; Berthold Bein
Journal:  Cell Signal       Date:  2009-05-27       Impact factor: 4.315

6.  Tuberculosis in twins: a re-analysis of the Prophit survey.

Authors:  G W Comstock
Journal:  Am Rev Respir Dis       Date:  1978-04

7.  Genome-wide analysis of insomnia in 1,331,010 individuals identifies new risk loci and functional pathways.

Authors:  Eus J W Van Someren; Danielle Posthuma; Philip R Jansen; Kyoko Watanabe; Sven Stringer; Nathan Skene; Julien Bryois; Anke R Hammerschlag; Christiaan A de Leeuw; Jeroen S Benjamins; Ana B Muñoz-Manchado; Mats Nagel; Jeanne E Savage; Henning Tiemeier; Tonya White; Joyce Y Tung; David A Hinds; Vladimir Vacic; Xin Wang; Patrick F Sullivan; Sophie van der Sluis; Tinca J C Polderman; August B Smit; Jens Hjerling-Leffler
Journal:  Nat Genet       Date:  2019-02-25       Impact factor: 38.330

8.  Changes of gene expression in T lymphocytes following Golli‑MBP gene RNA interference.

Authors:  Juanyong Xu; Dandan Zhu; Jing Shan; Yuan Fan
Journal:  Mol Med Rep       Date:  2016-10-13       Impact factor: 2.952

9.  Minimal Sex-Differential Modulation of Reactivity to Pathogens and Toll-Like Receptor Ligands following Infant Bacillus Calmette-Guérin Russia Vaccination.

Authors:  Fatoumatta Darboe; Jane U Adetifa; John Reynolds; Safayet Hossin; Magdalena Plebanski; Mihai G Netea; Sarah L Rowland-Jones; Jayne S Sutherland; Katie L Flanagan
Journal:  Front Immunol       Date:  2017-09-08       Impact factor: 7.561

10.  A global transcriptional network connecting noncoding mutations to changes in tumor gene expression.

Authors:  Wei Zhang; Ana Bojorquez-Gomez; Daniel Ortiz Velez; Guorong Xu; Kyle S Sanchez; John Paul Shen; Kevin Chen; Katherine Licon; Collin Melton; Katrina M Olson; Michael Ku Yu; Justin K Huang; Hannah Carter; Emma K Farley; Michael Snyder; Stephanie I Fraley; Jason F Kreisberg; Trey Ideker
Journal:  Nat Genet       Date:  2018-04-02       Impact factor: 41.307

View more
  1 in total

1.  Up-regulated long noncoding RNA AC007128.1 and its genetic polymorphisms associated with Tuberculosis susceptibility.

Authors:  Hong Yan; Guoye Liu; Yuan Liang; Wei Wu; Rui Xia; Lin Jiao; Han Shen; Zhijun Jia; Qian Wang; Zhiqiang Wang; Yi Kong; Binwu Ying; Hualiang Wang; Chengbin Wang
Journal:  Ann Transl Med       Date:  2021-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.